Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE-DM2: Bofanglutide vs Semaglutide in Type 2 Diabetes Mellitus
NCT07628985Phase 3Not yet recruiting
- Sponsor
- Carnot Laboratorios
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 3 trial of bofanglutide in type 2 diabetes mellitus (T2DM), sponsored by Carnot Laboratorios. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
bofanglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07628985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07628985.